Literature DB >> 3484963

Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.

I M Nilsson, P Felding, I Lecander, C Lennér, B Astedt.   

Abstract

The content of tissue plasminogen activator inhibitor (t-PA-I), and of specific pregnancy plasma-PA-I reacting with antibodies to placental-PA-I, was measured in platelet-poor plasma (PPP), platelet-rich plasma (PRP), serum and platelet lysate, both from pregnant women and healthy non-pregnant (male or female) controls. Inhibitory activity was much higher in PPP from pregnant women than in PPP from controls, though it was comparable in platelet lysates both from pregnant women and from controls. The specific pregnancy Plasma-PA-I was present in high concentration in pregnancy PPP, but absent in PPP from the controls and also absent in platelet lysates from both pregnant women and controls. The results show that the specific pregnancy plasma-PA-I is not identical to either the PA-I in platelet lysate or to the PA-I in PPP from non-pregnant controls.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484963     DOI: 10.1111/j.1365-2141.1986.tb02924.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.

Authors:  Z Y Hu; Y X Liu; K Liu; S Byrne; T Ny; Q Feng; C D Ockleford
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

Review 2.  Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.

Authors:  D de Bono
Journal:  Br Heart J       Date:  1994-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.